Life sciences partnering, done for you
Expert-led search, outreach and warm introductions to the right partners and investors. We find the companies and funds that fit your asset, reach the people who decide, and introduce you to those who confirm interest.
Why BioHub exists
Finding a licensing partner or an investor usually means months of desk research, cold emails that go unanswered and conferences that miss the right person. Smaller companies rarely have a business development team to do this full time.
We do that work for you. AI-assisted search across 14,900+ life sciences organisations finds the candidates. Experienced industry professionals decide who fits, and open the door.
How it works
We meet you to agree what you are offering, what you need and which partners would fit. Our team drafts the brief and you sign it off.
You receive
We identify the companies and investors that match the brief, and the decision-makers there in business development, licensing, and search & evaluation.
You receive
We contact them in your name with a short non-confidential summary, follow up, and put you in touch with those who confirm interest.
You receive
What you get
The companies and funds that match your brief: pharma and larger biotech that could license, co-develop or acquire, and investors that could fund the next stage.
The right people at each counterparty: Director to VP level in business development, licensing, search & evaluation and strategy, with verified contact details.
We contact them in your name by email and LinkedIn, handle the follow-ups, and introduce you to those who confirm interest. Nothing confidential is shared before a confidentiality agreement.
Who it's for
Biotech and pharma companies looking for a licensing partner, a co-development partner, an acquirer or an investor, without a business development team to run the search.
We only contact you about opportunities that match your company's focus, starting with a short non-confidential summary. If it fits, we arrange a confidentiality agreement and an introduction. If it does not, a short reply is all we ask.
Why BioHub
Every brief and partner map is reviewed by experienced pharma business development and licensing professionals. The search is assisted by AI; the judgement is human.
14,900+ life sciences organisations in our database, matched against your brief and enriched with current decision-maker contacts.
Three staged fees: the brief, the partner map, and a fee per counterparty that confirms interest. You stop after any step and keep what we delivered.
Outreach starts with a non-confidential summary. Details are shared only under a confidentiality agreement, and only with counterparties that confirm interest.
Pricing
Each gate is invoiced when its deliverable is handed over, and you decide whether to continue. The last gate is charged per counterparty that confirms interest, so most of the price falls due only when there is someone to talk to.
A fixed fee for the intake meeting and the one-page brief.
A fixed fee for the ranked map and the decision-maker contacts at each counterparty.
A fee per counterparty that confirms interest, invoiced monthly. You can cap the number up front.
Questions
A one-page description of what you want to partner: the asset, indication and stage, the deal structures you would consider, the geographies, named targets and exclusions. We draft it with you in a one-hour meeting, and it drives everything that follows.
Counterparties first receive a short non-confidential summary. Details are shared only after a confidentiality agreement is in place, and only with those who have confirmed interest.
Our team contacts the decision-makers in your name, by email and LinkedIn, follows up in waves and tracks every reply. You see who was contacted, who replied and who wants to talk.
You pay for the brief and the partner map only. The per-introduction fee is due only when a counterparty confirms interest, so our revenue depends on your results.
Yes. Send it with your enquiry. We will tell you whether it is ready to use as it is, or what we would add before starting the partner map.
It depends on the geography and on how many counterparties are on the map. We agree a timeline when you sign off the brief, and you see progress as the replies come in.
Contact
Send us a few lines about the asset and what you are looking for. We will come back to you to arrange a short call and prepare the brief.